Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study

29 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in prevention, interventions and outcomes Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017